NR1H4 and Pruritus: For instance, Obeticholic acid (OCA), the farnesoid X receptor (FXR) agonist targeting BA signaling, showed efficacy in improving fibrosis, but its clinical use is hampered by 50% incidence of pruritus (Younossi et al., 2019).